Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncocyte Corporation logo

SEC Form 4: Last Andrew J. converted options into 10,000 shares, increasing direct ownership by 33% to 40,170 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCX (Oncocyte Corporation) and more on Quantisnow.

SEC Form 4: Last Andrew J. converted options into 10,000 shares, increasing direct ownership by 33% to 40,170 units | Quantisnow